Articles

Deal helps expands software company’s labeling capabilities in clinical trial, med device and pharma spaces

Loftware acquires PRISYM ID

Protagen, BioAnalytix and GeneWerk merger set to target biopharma, C&GT sectors

Three firms join forces to form ProtaGene, a new CRO

Tufts analysis uncovers various benefits to conducting decentralized clinical trials—including financial benefits

DCTs can offer net benefits ranging from five to 14 times, study says

Will welcome seven temperature-controlled processing suites to accommodate various biologic drug needs

Catalent boosts cold chain packaging services

Partnership enhances CBM’s manufacturing capabilities in C&GT space

SK Inc. invests $350 million in Center for Breakthrough Medicines

Syneos Health’s annual survey reveals the potential for shifts in the M&A space

Analysis: Smaller biotech firms to continue taking the lead on dealmaking in 2022

Center’s 89,000 square-foot expansion expected to double its capacity

Fujifilm grows lab space at North Carolina facility

Strategic collaboration will feature Mammoth’s CRISPR know-how to design in vivo therapies

Bayer, Mammoth Biosciences ink novel gene editing technology deal

What are the key characteristics of hybrid direct-to-patient studies and supply chain structures that can make them a standard consideration for clinical trial adoption?

The benefits of hybrid DtP supply chain models for patient drug access 

Emergency-use clearance of Pfizer drug a major milestone in the fight against the now-omicron-fueled virus in the US  

Clinical Operations